预防炎症和免疫性疾病中的心力衰竭
Preventing Heart Failure in Inflammatory and Immune Disorders.
作者信息
Serhal Maya, Longenecker Chris T
机构信息
University Hospitals Case Medical Center, Cleveland, OH, USA.
University Hospitals Case Medical Center, Cleveland, OH, USA ; Case Western Reserve University School of Medicine, Cleveland, OH, USA.
出版信息
Curr Cardiovasc Risk Rep. 2014 Jun;8(8). doi: 10.1007/s12170-014-0392-7.
Abstract
Patients with chronic inflammatory diseases are at increased risk for heart failure due to ischemic heart disease and other causes including heart failure with preserved ejection fraction. Using rheumatoid arthritis and treated HIV infection as two prototypical examples, we review the epidemiology and potential therapies to prevent heart failure in these populations. Particular focus is given to anti-inflammatory therapies including statins and biologic disease modifying drugs. There is also limited evidence for lifestyle changes and blockade of the renin-angiotensin-aldosterone system. We conclude by proposing how a strategy for heart failure prevention, such as the model tested in the Screening To Prevent Heart Failure (STOP-HF) trial, may be adapted to chronic inflammatory disease.
摘要
患有慢性炎症性疾病的患者因缺血性心脏病和其他原因（包括射血分数保留的心力衰竭）而患心力衰竭的风险增加。以类风湿性关节炎和接受治疗的HIV感染这两个典型例子为例，我们回顾了这些人群中预防心力衰竭的流行病学和潜在疗法。特别关注了包括他汀类药物和生物疾病改善药物在内的抗炎疗法。生活方式改变和肾素-血管紧张素-醛固酮系统阻断的证据也有限。我们通过提出如何将心力衰竭预防策略（如在预防心力衰竭筛查试验（STOP-HF）中测试的模型）应用于慢性炎症性疾病来得出结论。
相似文献
1
Preventing Heart Failure in Inflammatory and Immune Disorders.预防炎症和免疫性疾病中的心力衰竭
Curr Cardiovasc Risk Rep. 2014 Jun;8(8). doi: 10.1007/s12170-014-0392-7.
2
Medical Therapies for Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭的医学治疗方法。
Hypertension. 2020 Jan;75(1):23-32. doi: 10.1161/HYPERTENSIONAHA.119.14057. Epub 2019 Dec 2.
3
Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.肾素 - 血管紧张素 - 醛固酮系统和交感神经系统在心力衰竭中的病理生理作用。
Am J Health Syst Pharm. 2004 May 1;61 Suppl 2:S4-13. doi: 10.1093/ajhp/61.suppl_2.S4.
4
PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016.PEARL-HF研究：使用新型聚合钾结合剂RLY5016预防心力衰竭患者高钾血症
Future Cardiol. 2012 Jan;8(1):17-28. doi: 10.2217/fca.11.71.
5
The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis.血管紧张素转换酶抑制剂和血管紧张素受体拮抗剂对射血分数保留心力衰竭患者死亡率和心力衰竭住院率的影响：系统评价和荟萃分析。
J Card Fail. 2010 Mar;16(3):260-7. doi: 10.1016/j.cardfail.2009.11.007. Epub 2010 Jan 6.
6
Renin-angiotensin-aldosterone system inhibitors in heart failure.肾素-血管紧张素-醛固酮系统抑制剂在心力衰竭中的应用。
Clin Pharmacol Ther. 2013 Oct;94(4):459-67. doi: 10.1038/clpt.2013.135. Epub 2013 Jul 12.
7
Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction.替代肾素-血管紧张素系统的血管紧张素（Angs）可预测射血分数保留的心力衰竭患者的结局。
Hypertension. 2019 Aug;74(2):285-294. doi: 10.1161/HYPERTENSIONAHA.119.12786. Epub 2019 Jun 24.
8
Hypertension in Patients with Heart Failure with Reduced Ejection Fraction.射血分数降低的心力衰竭患者的高血压
Curr Cardiol Rep. 2016 Dec;18(12):127. doi: 10.1007/s11886-016-0807-9.
9
Management of heart failure with preserved ejection fraction: a review.射血分数保留的心力衰竭的管理：综述
Clin Ther. 2015 Oct 1;37(10):2186-98. doi: 10.1016/j.clinthera.2015.08.005. Epub 2015 Sep 16.
10
Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.改善心外膜脂肪组织炎症的药物在射血分数保留型心力衰竭与射血分数降低型心力衰竭中的作用可能不一致。
J Card Fail. 2019 Dec;25(12):986-1003. doi: 10.1016/j.cardfail.2019.09.002. Epub 2019 Sep 18.
引用本文的文献
1
Adiponectin up-regulates the decrease of myocardial autophagic flux induced by β -adrenergic receptor autoantibody partly dependent on AMPK.脂联素部分依赖 AMPK 上调β-肾上腺素能受体自身抗体诱导的心肌自噬通量下降
J Cell Mol Med. 2021 Sep;25(17):8464-8478. doi: 10.1111/jcmm.16807. Epub 2021 Jul 29.
2
HIV and cardiovascular disease.艾滋病毒与心血管疾病。
Lancet HIV. 2020 Apr;7(4):e279-e293. doi: 10.1016/S2352-3018(20)30036-9.
3
Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.人类免疫缺陷病毒感染患者的心力衰竭：流行病学与管理差异
Int J Cardiol. 2016 Sep 1;218:43-46. doi: 10.1016/j.ijcard.2016.05.027. Epub 2016 May 13.
本文引用的文献
1
Increased benefit of interleukin-1 inhibition on vascular function, myocardial deformation, and twisting in patients with coronary artery disease and coexisting rheumatoid arthritis.白细胞介素-1抑制对合并类风湿性关节炎的冠心病患者血管功能、心肌变形及扭转的益处增加。
Circ Cardiovasc Imaging. 2014 Jul;7(4):619-28. doi: 10.1161/CIRCIMAGING.113.001193. Epub 2014 Apr 29.
2
Associations between HIV infection and subclinical coronary atherosclerosis.HIV 感染与亚临床冠状动脉粥样硬化的关联。
Ann Intern Med. 2014 Apr 1;160(7):458-67. doi: 10.7326/M13-1754.
3
Effects of physical activity and sedentary time on the risk of heart failure.体力活动和久坐时间对心力衰竭风险的影响。
Circ Heart Fail. 2014 Jan;7(1):21-7. doi: 10.1161/CIRCHEARTFAILURE.113.000529.
4
Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis.辛伐他汀可呈剂量依赖性抑制类风湿关节炎患者的细胞因子。
Inflamm Res. 2014 Apr;63(4):309-15. doi: 10.1007/s00011-013-0702-4. Epub 2014 Jan 14.
5
Interleukin-1 blockade in rheumatoid arthritis and heart failure: a missed opportunity?
Int J Cardiol. 2014 Feb 15;171(3):e125-6. doi: 10.1016/j.ijcard.2013.12.078. Epub 2013 Dec 28.
6
Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.接受抗逆转录病毒治疗的 HIV 感染患者中，24 周他汀类药物治疗对全身和血管炎症的影响。
J Infect Dis. 2014 Apr 15;209(8):1156-64. doi: 10.1093/infdis/jiu012. Epub 2014 Jan 9.
7
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study.白细胞介素-6受体阻断对类风湿关节炎血管风险替代指标的影响：MEASURE，一项随机、安慰剂对照研究。
Ann Rheum Dis. 2015 Apr;74(4):694-702. doi: 10.1136/annrheumdis-2013-204345. Epub 2013 Dec 24.
8
Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complications.吡格列酮与运动训练对合并代谢并发症的HIV阳性个体基础心肌底物代谢及左心室功能影响的初步研究
HIV Clin Trials. 2013 Nov-Dec;14(6):303-12. doi: 10.1310/hct1406-303.
9
Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?在高 CD4 细胞计数时启动抗逆转录病毒治疗：是否能降低心血管疾病的风险？
Curr Opin HIV AIDS. 2014 Jan;9(1):54-62. doi: 10.1097/COH.0000000000000015.
10
Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study).阿那白滞素阻断白细胞介素-1对射血分数保留心力衰竭患者有氧运动能力的影响（来自 D-HART 初步研究）。
Am J Cardiol. 2014 Jan 15;113(2):321-327. doi: 10.1016/j.amjcard.2013.08.047. Epub 2013 Oct 4.
Zotero 插件